HYPMY (Hypera) FCF Margin % : 28.71% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Hypera FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Hypera's Free Cash Flow for the three months ended in Dec. 2024 was $71 Mil. Hypera's Revenue for the three months ended in Dec. 2024 was $248 Mil. Therefore, Hypera's FCF Margin % for the quarter that ended in Dec. 2024 was 28.71%.

As of today, Hypera's current FCF Yield % is 14.96%.

The historical rank and industry rank for Hypera's FCF Margin % or its related term are showing as below:

HYPMY' s FCF Margin % Range Over the Past 10 Years
Min: -18.2 Med: 17.02 Max: 23.75
Current: 23.46

During the past 13 years, the highest FCF Margin % of Hypera was 23.75%. The lowest was -18.20%. And the median was 17.02%.

HYPMY's FCF Margin % is ranked better than
92.76% of 981 companies
in the Drug Manufacturers industry
Industry Median: 0.86 vs HYPMY: 23.46

Hypera FCF Margin % Historical Data

The historical data trend for Hypera's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera FCF Margin % Chart

Hypera Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-18.20

9.44

7.01

20.00

23.75

Hypera Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															31.43	17.45	21.18	28.76	28.71

Competitive Comparison of Hypera's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypera's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Hypera's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Hypera FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Hypera's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	289.679	/	1219.876
	=	23.75 %

Hypera's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	71.105	/	247.663
	=	28.71 %

Hypera FCF Margin % Related Terms

Thank you for viewing the detailed overview of Hypera's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

HM6A:Germany HYPE3:Brazil

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.